CML, chronic phase
Clinical trials for CML, chronic phase explained in plain language.
Never miss a new study
Get alerted when new CML, chronic phase trials appear
Sign up with your email to follow new studies for CML, chronic phase, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug takes aim at Treatment-Resistant leukemia
Disease control Recruiting nowResearchers are comparing olverembatinib, an experimental drug, with bosutinib, an approved drug, in adults with chronic phase chronic myeloid leukemia (CML-CP). The trial enrolls patients whose disease has not responded well to at least two prior targeted treatments. A separate …
Matched conditions: CML, CHRONIC PHASE
Phase 3 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a new pill rescue patients when standard leukemia drugs stop working?
Disease control Recruiting nowThis phase 3 trial tests the drug radotinib in adults with chronic-phase chronic myeloid leukemia (CML) who have not responded to or could not tolerate earlier treatments such as imatinib. Participants take radotinib twice daily, and researchers measure how well it reduces leukem…
Matched conditions: CML, CHRONIC PHASE
Phase 3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC